Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications

Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications Pharmacometrics is the science of using quantitative analysis and modelling and simulation (M&S) approaches to inform and enhance drug development and regulatory review. Pharmacometrics also encompasses quantitative system pharmacology and model-informed drug development (MIDD) approaches. 2022-06-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetypharmacometricsdrug submissionsclinical trial applicationsquantitative analysismodelling-simulation approachesquantitative system pharmacologymodel-informed drug-development approaches Policy statement: Use of pharmacometrics in drug submissions and clinical trial applicationsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/policy-pharmacometrics-drug-submissions-clinical-trials-applications.html Policy statement: Use of pharmacometrics in drug submissions and clinical trial applicationsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/produits-biologiques-radiopharmaceutiques-therapies-genetiques/information-demandes-presentations/lignes-directrices/politique-pharmacometrie-presentations-medicaments-demandes-essais-cliniques.html

Pharmacometrics is the science of using quantitative analysis and modelling and simulation (M&S) approaches to inform and enhance drug development and regulatory review. Pharmacometrics also encompasses quantitative system pharmacology and model-informed drug development (MIDD) approaches.

Data and Resources

Similar records